Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | CHIEF STRATEGY OFFICER | August 30, 2024 | September 04, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date August 30, 2024 · Filed September 04, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,465 |
Ending reported balance
After 2024-09-03 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2024-08-30 · Exercise / conversion · Acquired 951 · Balance 29,273 F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Row 2 · 2024-08-30 · Exercise / conversion · Acquired 1,179 · Balance 30,452 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 3 · 2024-08-30 · Exercise / conversion · Acquired 2,790 · Balance 33,242 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 4 · 2024-09-03 · Sale · Disposed 1,777 · Balance 31,465 F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 5,706 |
Reported balance
After 2024-08-30 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-08-30 · Exercise / conversion · Disposed 951 · Balance 5,706 F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,359 |
Reported balance
After 2024-08-30 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2024-08-30 · Exercise / conversion · Disposed 1,179 · Balance 2,359 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5: On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 16,742 |
Reported balance
After 2024-08-30 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2024-08-30 · Exercise / conversion · Disposed 2,790 · Balance 16,742 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6: On March 3, 2023, the reporting person was granted 33,482 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5: On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6: On March 3, 2023, the reporting person was granted 33,482 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 17, 2023 Filed May 18, 2023 20:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $23.81 | $23,810.00 |
DisclosureSEC source: 0001415889-23-008270 · form4-05182023_080502.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,520 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $25.30 | $25,300.00 |
DisclosureSEC source: 0001415889-23-006592 · form4-04182023_080404.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,520 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| March 17, 2023 Filed Mar 20, 2023 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $25.13 | $25,130.00 |
DisclosureSEC source: 0001415889-23-005210 · form4-03202023_080349.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,520 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:19 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 33,482 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004418 · form4-03072023_090310.xml · derivative · entry 2 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,482 Underlying: Common Stock · 33,482 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:19 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,838 | $25.91 | $47,624.42 |
DisclosureSEC source: 0001415889-23-004418 · form4-03072023_090310.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,520 F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 365 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004091 · form4-03032023_090316.xml · derivative · entry 16 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364 Underlying: Common Stock · 365 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F13 · derivative.exercise_date: On March 2, 2023, the reporting person earned 729 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. F13 · derivative.expiration_date: On March 2, 2023, the reporting person earned 729 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 729 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004091 · form4-03032023_090316.xml · derivative · entry 15 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 729 Underlying: Common Stock · 729 shares Expires not disclosed F10 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F11 · shares: Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2022. F12 · derivative.exercise_date: The performance stock units vest in two substantially equal annual installments beginning on March 2, 2023. F12 · derivative.expiration_date: The performance stock units vest in two substantially equal annual installments beginning on March 2, 2023. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 723 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004091 · form4-03032023_090316.xml · derivative · entry 14 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 722 Underlying: Common Stock · 723 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F9 · derivative.exercise_date: On March 2, 2022, the reporting person earned 2,168 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. F9 · derivative.expiration_date: On March 2, 2022, the reporting person earned 2,168 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 956 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004091 · form4-03032023_090316.xml · derivative · entry 13 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 956 Underlying: Common Stock · 956 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F8 · derivative.exercise_date: On March 2, 2021, the reporting person was granted 2,868 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F8 · derivative.expiration_date: On March 2, 2021, the reporting person was granted 2,868 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 430 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004091 · form4-03032023_090316.xml · derivative · entry 12 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 430 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F7 · derivative.exercise_date: On March 2, 2022, the reporting person earned 859 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022. F7 · derivative.expiration_date: On March 2, 2022, the reporting person earned 859 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004091 · form4-03032023_090316.xml · derivative · entry 11 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,706 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 2, 2021, the reporting person earned 5,120 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. F6 · derivative.expiration_date: On March 2, 2021, the reporting person earned 5,120 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,004 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004091 · form4-03032023_090316.xml · derivative · entry 10 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,004 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 2, 2020, the reporting person was granted 3,012 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On March 2, 2020, the reporting person was granted 3,012 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 365 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004091 · form4-03032023_090316.xml · nonDerivative · entry 8 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 723 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004091 · form4-03032023_090316.xml · nonDerivative · entry 7 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 956 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004091 · form4-03032023_090316.xml · nonDerivative · entry 6 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,270 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 430 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004091 · form4-03032023_090316.xml · nonDerivative · entry 5 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,706 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004091 · form4-03032023_090316.xml · nonDerivative · entry 4 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,004 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004091 · form4-03032023_090316.xml · nonDerivative · entry 3 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,178 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,950 | $25.36 | $49,455.90 |
DisclosureSEC source: 0001415889-23-004091 · form4-03032023_090316.xml · nonDerivative · entry 2 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,174 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 4,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004091 · form4-03032023_090316.xml · derivative · entry 9 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,433 Underlying: Common Stock · 4,716 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,716 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004091 · form4-03032023_090316.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $30.21 | $30,210.00 |
DisclosureSEC source: 0001415889-23-002849 · form4-02212023_090206.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,408 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $26.80 | $26,800.00 |
DisclosureSEC source: 0001415889-23-001056 · form4-01182023_090118.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,408 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| December 19, 2022 Filed Dec 20, 2022 21:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $26.93 | $26,930.00 |
DisclosureSEC source: 0001415889-22-012844 · form4-12202022_091244.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,408 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| November 17, 2022 Filed Nov 18, 2022 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $30.14 | $30,140.00 |
DisclosureSEC source: 0001415889-22-011583 · form4-11182022_091111.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,408 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| October 17, 2022 Filed Oct 18, 2022 20:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $24.04 | $24,040.00 |
DisclosureSEC source: 0001415889-22-010634 · form4-10182022_011004.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,408 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| September 19, 2022 Filed Sep 20, 2022 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $30.18 | $30,180.00 |
DisclosureSEC source: 0001415889-22-009794 · form4-09202022_010910.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,408 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 20:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $37.50 | $37,500.00 |
DisclosureSEC source: 0001415889-22-008817 · form4-08182022_010809.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,408 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| July 18, 2022 Filed Jul 19, 2022 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $41.12 | $41,120.00 |
DisclosureSEC source: 0001415889-22-007757 · form4-07192022_010710.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,408 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| June 17, 2022 Filed Jun 21, 2022 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $29.12 | $29,120.00 |
DisclosureSEC source: 0001415889-22-006813 · form4-06212022_010603.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,408 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:19 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantEmployee Stock Option (right to buy) · Derivative | 49,377 | $0.00 Strike: $32.62 | $0.00 |
DisclosureSEC source: 0001415889-22-006101 · form4-06032022_010637.xml · derivative · entry 1 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,377 Underlying: Common Stock · 49,377 shares Expires 2032-05-31 F1 · derivative.exercise_date: The option will vest as to one-third of the shares on June 1, 2023. The remainder of the shares will vest in 24 substantially equal monthly installments thereafter. Read SEC document |
| March 07, 2022 Filed Mar 8, 2022 21:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,642 | $66.74 | $109,582.15 |
DisclosureSEC source: 0001179110-22-002052 · edgar.xml · nonDerivative · entry 3 Trencher Daniel · CIK 0001830122 · SVP Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,408 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 2,567 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-002052 · edgar.xml · derivative · entry 5 Trencher Daniel · CIK 0001830122 · SVP Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,567 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On February 26, 2020, the reporting person earned 7,701 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2020. F5 · derivative.expiration_date: On February 26, 2020, the reporting person earned 7,701 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2020. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,974 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-002052 · edgar.xml · derivative · entry 4 Trencher Daniel · CIK 0001830122 · SVP Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,974 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 4, 2019, the reporting person was granted 5,922 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On March 4, 2019, the reporting person was granted 5,922 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,567 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-002052 · edgar.xml · nonDerivative · entry 2 Trencher Daniel · CIK 0001830122 · SVP Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,974 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-002052 · edgar.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · SVP Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,483 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 23:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,797 | $70.24 | $126,219.48 |
DisclosureSEC source: 0001415889-22-002578 · form4-03042022_030314.xml · nonDerivative · entry 6 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,509 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 723 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002578 · form4-03042022_030314.xml · derivative · entry 13 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,445 Underlying: Common Stock · 723 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F13 · derivative.exercise_date: On March 2, 2022, the reporting person earned 2,168 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. F13 · derivative.expiration_date: On March 2, 2022, the reporting person earned 2,168 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 2,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002578 · form4-03042022_030314.xml · derivative · entry 12 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,168 Underlying: Common Stock · 2,168 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F11 · shares: Performance award amount determined based on metrics in respect of the issuer's 2021 financial results F12 · derivative.exercise_date: The performance stock units vest in three substantially equal annual installments beginning on March 2, 2022. F12 · derivative.expiration_date: The performance stock units vest in three substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 956 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002578 · form4-03042022_030314.xml · derivative · entry 11 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,912 Underlying: Common Stock · 956 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F10 · derivative.exercise_date: On March 2, 2021, the reporting person was granted 2,868 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F10 · derivative.expiration_date: On March 2, 2021, the reporting person was granted 2,868 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 429 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002578 · form4-03042022_030314.xml · derivative · entry 10 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430 Underlying: Common Stock · 429 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F9 · derivative.exercise_date: On March 2, 2022, the reporting person earned 859 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022. F9 · derivative.expiration_date: On March 2, 2022, the reporting person earned 859 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 859 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002578 · form4-03042022_030314.xml · derivative · entry 9 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 859 Underlying: Common Stock · 859 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F7 · shares: Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2021. F8 · derivative.exercise_date: The performance stock units vest in two substantially equal annual installments beginning on March 2, 2022. F8 · derivative.expiration_date: The performance stock units vest in two substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002578 · form4-03042022_030314.xml · derivative · entry 8 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,706 Underlying: Common Stock · 1,708 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 2, 2021, the reporting person earned 5,120 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. F5 · derivative.expiration_date: On March 2, 2021, the reporting person earned 5,120 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,004 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002578 · form4-03042022_030314.xml · derivative · entry 7 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,004 Underlying: Common Stock · 1,004 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 2, 2020, the reporting person was granted 3,012 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On March 2, 2020, the reporting person was granted 3,012 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 723 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-002578 · form4-03042022_030314.xml · nonDerivative · entry 5 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,306 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 956 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-002578 · form4-03042022_030314.xml · nonDerivative · entry 4 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,583 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 429 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-002578 · form4-03042022_030314.xml · nonDerivative · entry 3 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,627 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,708 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-002578 · form4-03042022_030314.xml · nonDerivative · entry 2 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,004 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-002578 · form4-03042022_030314.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · SVP CORPORATE STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 14,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-001914 · edgar.xml · derivative · entry 1 Trencher Daniel · CIK 0001830122 · SVP Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,149 Underlying: Common Stock · 14,149 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F2 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.